Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
EmailIphone Application    Posted: 19th August 2020
If you would like to forward this story on to a friend, simply fill in the form below and click send.
Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Updated advice on lactating cow intramammary antibiotics
The VMD was informed of supply problems with certain lactating cow antibiotics earlier this year.

Multiject IMM Intramammary Suspension will arrive January 2021.

The Veterinary Medicines Directorate (VMD) has updated its advice on the availability of lactating cow intramammary antibiotics.

Earlier this year, the VMD were informed by Marketing Authorisation Holders (MAHs) of supply problems with certain lactating cow intramammary antibiotics.

On Tuesday (18 August) the list of anticipated resolution dates was updated. Combiclav Intramammary Suspension for Lactating Cows is now expected November 2020 while Multiject IMM Intramammary Suspension will arrive January 2021.

The full list is as follows:

Product Anticipated Resolution Date
Synulox Lactating Cow Intramammary Suspension (42058/4143) October-December 2020
Tetra-Delta Intramammary Suspension (42058/4152) October-December 2020
Ubro Yellow Milking Cow Intramammary Suspension (08327/4305) Product discontinued – no return date
Multiject IMM Intramammary Suspension (02000/4062) January 2021
Albiotic 330mg/100mg Intramammary Solution (30282/4035)  End of July 2020
Mastiplan LC, 300mg/20mg Intramammary Suspension (01708/4534)  End of June 2020
Cobactan MC Intramammary Suspension for Lactating Cows (42810/4000 End of June 2020
Combiclav Intramammary Suspension for Lactating Cows (02000/4424)  November 2020

The following lactating cow intramammary products have been reported as available for veterinary surgeons to purchase:

Ubropen 600 mg Intramammary Suspension for Lactating Cows (42810/4000)
Ubrolexin Intramammary Suspension for Lactating Dairy Cows (08327/4306)
Procapen Injector 3g intramammary suspension for cattle (24745/4023)
Orbenin L.A. 200mg Intramammary Suspension (42058/4090)
Pathocef 250mg Intramammary Suspension (42058/4094)*
Cefimam LC, 75 mg Intramammary
Pathocef 250mg Intramammary Suspension (42058/4094)*
Cefimam LC, 75 mg Intramammary Ointment for Lactating Cows (02000/4387)

Further details on the supply situation for individual UK-authorised product can be obtained through the MAH or a wholesale dealer.

 

Become a member or log in to add this story to your CPD history

Webinar to explore AMR in vet dentistry

News Story 1
 The WSAVA has invited veterinary professionals to a webinar on responsible antibiotic usage in dentistry.

On 19 November 2025, at 1am, Dr J Scott Weese and Dr Brooke Niemiec will share the latest advice for antimicrobial use. They will present research on oral bacterology, and explain how attendees can choose appropriate antibiotics.

The session will cover pre-, intra- and post-operative guidelines, with recommendations for various pathologies.

The webinar is designed to support veterinary professionals to make informed decisions and tackle antimicrobial resistance.

Attendees can register here. 

Click here for more...
News Shorts
Dechra launches checklist for veterinary sustainability

Global animal health specialist Dechra has announced the world's first Veterinary Green Theatre Checklist (VGTC) to help make surgery more sustainable.

Endorsed by leading veterinary organisations, including the BEVA, BVNA and RCVS Knowledge, the checklist is designed to reduce the environmental footprint of veterinary care, while supporting better animal health outcomes.

The checklist was launched at the World Congress of Veterinary Anaesthesia and Analgesia in Paris and will be followed by an internal training and awareness campaign. For more information, visit dechra.com